In human colon cancer, USP10 and SIRT6 protein expressions were reduced, and USP10 antagonized c-Myc transcriptional activity through SIRT6 and p53 to inhibit cell cycle progression, cancer cell growth, and tumor formation [31]. Here, MYC is linked to malignant colon neoplasm.